DBV Technologies | DBVT - SCHULD

Aktienkurs
20.05
Täglich Wechseln
0.56 2.85%
Monatlich
-1.55%
Jährlich
113.47%
Q2 Prognose
19.41




SCHULD Veränderung Datum
Acadia Pharmaceuticals USD 52.19M 2.62M 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Amarin USD 0 0 2025-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
BioMarin Pharmaceutical USD 605.86M 1.62M 2025-12
DBV Technologies USD 8.59M 295K 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Galectin Therapeutics USD 71.74M 10.6M 2023-12
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Incyte USD 39.43M 982K 2026-03
Insmed USD 727.89M 163.33M 2025-12
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Neurocrine Biosciences USD 415.3M 13.1M 2025-12
PTC Therapeutics USD 2.71B 2.42B 2025-12
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12